Loading
A phase 2 trial of Temoporfin in Nasopharyngeal carcinoma, run by Ministry of Health, Malaysia, with a status the registry has not verified recently.
Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma is a phase 2 interventional study registered as NCT01086488 by Ministry of Health, Malaysia, with 66 participants planned, started 2009-01 and due to reach its primary completion in 2011-09. Interventions recorded: FOSCAN. Conditions recorded: Nasopharyngeal Carcinoma.
Linked to the drug Temoporfin because the registry names it among its interventions and Nasopharyngeal carcinoma among its conditions. Registry record only: no result has been read by an editor.
Shares Temoporfin and the tag pipeline.
Shares Temoporfin and the tag pipeline.
Shares Recurrent and metastatic nasopharyngeal carcinoma, Nasopharyngeal carcinoma and the tag pipeline.
Shares Nasopharyngeal carcinoma and the tag pipeline.
Shares Recurrent and metastatic nasopharyngeal carcinoma, Nasopharyngeal carcinoma and the tag pipeline.
Shares Recurrent and metastatic nasopharyngeal carcinoma, Nasopharyngeal carcinoma and the tag pipeline.
Shares Recurrent and metastatic nasopharyngeal carcinoma, Nasopharyngeal carcinoma and the tag pipeline.
Shares Nasopharyngeal carcinoma and the tag pipeline.